Stock UniverseDerived research view · source repositories remain read-only

Veradermics, Incorporated (MANE)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Qualified
Selection Score
37.70
Global Rank
765
Market Cap
1.71B
Latest Close
91.69
RS Composite
41.93% · G#179

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-16.47%
3M
88.82%
6M
142.89%
1Y
142.89%
3Y
142.89%
5Y
142.89%
10Y
142.89%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 532.42K · 30-day average: 706.79K · Max drawdown over stored range: -20.13%

Research Snapshot

Relative Strength vs SPX

RS Composite41.93%
20D RS-15.62%
60D RS70.71%
120D RSn/a
Global RS Rank179 · 94.66% percentile
Qualified+ RS Rank83 · 93.40% percentile
Group ScopeQualified+
Primary RS Rank28 · 93.89% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank122 / 701
Primary Percentile82.74
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for MANE.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2023FY 2024FY 2025
Revenue
Revenue Growth (YoY)
Gross Profit
Operating Income-17.324-26.778
Free Cash Flow-13.51-23.688-71.626
Free Cash Flow Per Share-18.3327-32.144-96.1434
EPS (Diluted) GAAP-22.376525-37.049501
EPS Growth
EPS Non-GAAP
Gross Margin
Operating Margin
Profit Margin
Free Cash Flow Margin
Shares Outstanding (Diluted)0.73690.73690.745
Shares Change (YoY)1.093%

SEC Quarterly Fundamentals

No processed quarterly rows for MANE.